July 2026
Cannabis
What July 2026's 7 new studies found, synthesized from the papers below. All Cannabis research →
The synthesis
Synthesized from 7 studies in the library · AI-generated, grounded in the abstracts below
Found by searching the library for Cannabis, marijuana, THC, tetrahydrocannabinol, then ranked by relevance.
Research published in July 2026 on cannabis spans several domains, but no single conclusion emerges. Studies indicate that cannabis, especially high-potency THC, may contribute to psychosis and violence, and that adolescent THC exposure can alter brain structure and Reelin signaling in mice. Neurophysiological studies show altered prefrontal connectivity and dynamic brain states in cannabis users, but these findings are preliminary and often based on small samples or animal models. Overall, the evidence is mixed and highlights the need for more rigorous, longitudinal research.
Evidence by study
Direction is which way each study's own result points, not our rating of the study.
What the directions mean
- Supports:
- the study found the intervention worked, or its hypothesis held.
- Opposes:
- it found the opposite, no benefit or a harm.
- No effect:
- no significant difference either way.
- Mixed:
- effects in both directions within the same study.
- Unclear:
- the abstract does not report a direction.
| Study | Design | Sample size | Direction | Finding |
|---|---|---|---|---|
| Cannabis, psychosis, and violence: case reports and comprehensive evidence review 2026 | perspective | Supports | Argues that cannabis, particularly high-potency THC, may contribute to psychosis and violence, and that toxicology in violence cases often omits THC testing. | |
| Disruption of Reelin signaling in a dual-hit mouse model of schizophrenia: impact of postnatal Δ9-tetrahydrocannabinol exposure in a maternal immune activation model 2026 | animal study | Supports | Adolescent THC exposure is a major driver of Reelin alterations, with prenatal immune activation potentially modulating this effect in a sex-dependent manner. | |
| Medicinal Plants with Psychoactive Properties: A Comprehensive Review 2026 | review | Mixed | Reviews twenty psychoactive medicinal plants, including Cannabis sativa, and reports neuropharmacological activities through modulation of serotonergic, dopaminergic, GABAergic, and endocannabinoid systems, but notes most evidence remains preclinical with limited clinical validation. | |
| Prefrontal connectivity alterations and oscillatory dynamics in cannabis use disorder. 2026 | case-control study | 46 | Supports | Delta-high gamma and beta-high gamma coupling in prefrontal regions, along with heightened frontal-parietal and frontal-temporal coherence during eye closure, distinguished cannabis users from controls. |
| Parallel-access compounds: unregulated availability as a consideration in research ethics 2026 | theoretical or philosophical paper | Unclear | Proposes that compounds available in both regulated clinical pipelines and unregulated markets, termed 'parallel-access compounds,' deserve recognition in research ethics. | |
| Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms 2026 | observational study | 2841 | Supports | Individuals who co-used psilocybin and alcohol had fewer depressive symptoms than those who used alcohol without psilocybin. |
| Dynamic Brain States With Cannabis Intoxication: Beyond "More Is Better" in Interpreting Brain Connectivity. 2026 | observational study | Supports | Cannabis intoxication shifts brain connectivity into more variable and less stable dynamic states, challenging a simple dose-response relationship. |
Argues that cannabis, particularly high-potency THC, may contribute to psychosis and violence, and that toxicology in violence cases often omits THC testing.
perspective
Adolescent THC exposure is a major driver of Reelin alterations, with prenatal immune activation potentially modulating this effect in a sex-dependent manner.
animal study
Reviews twenty psychoactive medicinal plants, including Cannabis sativa, and reports neuropharmacological activities through modulation of serotonergic, dopaminergic, GABAergic, and endocannabinoid systems, but notes most evidence remains preclinical with limited clinical validation.
review
Delta-high gamma and beta-high gamma coupling in prefrontal regions, along with heightened frontal-parietal and frontal-temporal coherence during eye closure, distinguished cannabis users from controls.
case-control study Sample size: 46
Proposes that compounds available in both regulated clinical pipelines and unregulated markets, termed 'parallel-access compounds,' deserve recognition in research ethics.
theoretical or philosophical paper
Individuals who co-used psilocybin and alcohol had fewer depressive symptoms than those who used alcohol without psilocybin.
observational study Sample size: 2841
Cannabis intoxication shifts brain connectivity into more variable and less stable dynamic states, challenging a simple dose-response relationship.
observational study
Points of agreement
- Cannabis exposure is associated with alterations in brain function and structure, including changes in connectivity and Reelin signaling.
- High-potency THC may be linked to psychosis and violence, though evidence is largely from case reports and perspectives.
- Cannabis is recognized as a psychoactive substance with potential therapeutic and adverse effects, but clinical validation is limited.
Conflicts
- The perspective argues cannabis may contribute to psychosis and violence, while the review notes limited clinical validation for therapeutic effects, but these are not directly contradictory.
- The observational study on psilocybin and alcohol co-use suggests potential benefits, but this is not directly about cannabis and may conflict with the negative associations of cannabis use.
Gaps
- Durability of effects and long-term outcomes are not addressed.
- Blinding and control conditions are often lacking in observational and case-control studies.
- Populations are limited to specific groups (e.g., mice, CUD participants, U.S. adults) and may not generalize.
- Dose-response relationships for cannabis potency and effects are not systematically studied.
- Theoretical papers propose frameworks but lack empirical data.